Drug interactions
Bendamustine + Talquetamab
Severity: Moderate
Bendamustine and Talquetamab: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Talquetamab causes cytokine release syndrome, which can transiently suppress CYP enzymes, including CYP1A2. This may alter bendamustine metabolism and exposure, although the clinical effect is uncertain.
What this interaction means in plain words
Bendamustine and Talquetamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bendamustine belongs to Oncology; Talquetamab belongs to Oncology.
Why it happens
Cytokine-mediated suppression of CYP1A2 during cytokine release may reduce bendamustine metabolism.
What to do
Monitor for bendamustine toxicity, especially myelosuppression, during talquetamab step-up dosing and for up to about two weeks after the first treatment dose and during CRS.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bendamustine and Talquetamab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Bendamustine
Other interactions of Talquetamab
- Clozapine + Talquetamab Major
- Pimozide + Talquetamab Major
- Carbamazepine + Talquetamab Moderate
- Clomipramine + Talquetamab Moderate
- Colchicine + Talquetamab Moderate
- Cyclosporin + Talquetamab Moderate
Frequently asked questions
Can I take Bendamustine with Talquetamab?
MediHelp rates the interaction as moderate. Bendamustine and Talquetamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Talquetamab causes cytokine release syndrome, which can transiently suppress CYP enzymes, including CYP1A2. This may alter bendamustine metabolism and exposure, although the clinical effect is uncertain.
How serious is the interaction between Bendamustine and Talquetamab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bendamustine toxicity, especially myelosuppression, during talquetamab step-up dosing and for up to about two weeks after the first treatment dose and during CRS.
What other medicines interact with Bendamustine?
MediHelp also lists interactions of Bendamustine with, for example, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Chlorambucil. The full list is on the Bendamustine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
